Vertaling van "about " (Frans → Nederlands) :

This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties.
DISCLOSURE NOTICE: The information contained in this release is as of September 1, 2010. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.

Accueil » About us » About the KCE
Startpagina » About us » About the KCE

· The three greatest caregiver concerns about the progression of their loved one’s AD were memory loss (41 percent), personal safety (33 percent) and confusion (27 percent)
The three greatest caregiver concerns about the progression of their loved one’s AD were memory loss (41 percent), personal safety (33 percent) and confusion (27 percent)

· 67 percent of AD caregivers surveyed named at least one change in cognitive symptoms as a main concern about the progression of their loved one’s AD
67 percent of AD caregivers surveyed named at least one change in cognitive symptoms as a main concern about the progression of their loved one’s AD

“In the face of this devastating chronic and progressive disease, it is important for AD caregivers to know about the available educational resources, support networks and treatments in order to enhance these discussions at all stages of the disease ”.
“In the face of this devastating chronic and progressive disease, it is important for AD caregivers to know about the available educational resources, support networks and treatments in order to enhance these discussions at all stages of the disease”.

· Men surveyed were more likely to be concerned about memory loss compared to women [50 percent versus 37 percent]
Men surveyed were more likely to be concerned about memory loss compared to women (50 percent versus 37 percent)

Additional information about AD and caregiver resources can be found at www.alzfdn.org .
Additional information about AD and caregiver resources can be found at www.alzfdn.org.

Copyright : Les rapports KCE sont publiés sous Licence Creative Commons « by/nc/nd » [http ...]
Copyright: De KCE-rapporten worden gepubliceerd onder de licentie Creative Commons " by/nc/nd" [http ...]

Accueil » About us » Contactez-nous
Startpagina » About us » Contacteer ons

For more information about Eisai, please visit www.eisai.com .
For more information about Eisai, please visit www.eisai.com.